HomeCompareOBSV vs MCD

OBSV vs MCD: Dividend Comparison 2026

OBSV yields 1964.64% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBSV wins by $8418661323.92M in total portfolio value
10 years
OBSV
OBSV
● Live price
1964.64%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8418661324.00M
Annual income
$7,652,437,982,425,691.00
Full OBSV calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — OBSV vs MCD

📍 OBSV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBSVMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBSV + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBSV pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBSV
Annual income on $10K today (after 15% tax)
$166,994.11/yr
After 10yr DRIP, annual income (after tax)
$6,504,572,285,061,837.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, OBSV beats the other by $6,504,572,285,039,543.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBSV + MCD for your $10,000?

OBSV: 50%MCD: 50%
100% MCD50/50100% OBSV
Portfolio after 10yr
$4209330662.04M
Annual income
$3,826,218,991,225,959.50/yr
Blended yield
90.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

OBSV
Analyst Ratings
9
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$6.00
+5793.9% upside vs current
Range: $6.00 — $6.00
Altman Z
-39.0
Piotroski
4/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBSV buys
0
MCD buys
0
No recent congressional trades found for OBSV or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBSVMCD
Forward yield1964.64%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$8418661324.00M$78.5K
Annual income after 10y$7,652,437,982,425,691.00$26,227.70
Total dividends collected$8364201739.80M$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$6.00$351.76

Year-by-year: OBSV vs MCD ($10,000, DRIP)

YearOBSV PortfolioOBSV Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$207,164$196,463.65$10,815$334.85+$196.3KOBSV
2$4,025,415$3,803,750.33$11,826$491.71+$4.01MOBSV
3$73,382,907$69,075,712.04$13,123$730.06+$73.37MOBSV
4$1,255,382,398$1,176,862,688.09$14,853$1,100.07+$1255.37MOBSV
5$20,159,078,828$18,815,819,662.20$17,257$1,690.61+$20159.06MOBSV
6$303,950,265,341$282,380,050,994.39$20,752$2,667.01+$303950.24MOBSV
7$4,304,301,356,343$3,979,074,572,429.02$26,103$4,354.83+$4304301.33MOBSV
8$57,267,735,234,320$52,662,132,783,032.35$34,794$7,437.78+$57267735.20MOBSV
9$716,096,580,908,859$654,820,104,208,136.60$49,926$13,461.60+$716096580.86MOBSV
10$8,418,661,323,998,170$7,652,437,982,425,691.00$78,550$26,227.70+$8418661323.92MOBSV

OBSV vs MCD: Complete Analysis 2026

OBSVStock

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

Full OBSV Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this OBSV vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBSV vs SCHDOBSV vs JEPIOBSV vs OOBSV vs KOOBSV vs MAINOBSV vs YUMOBSV vs QSROBSV vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.